The Head of Regulatory Affairs Strategy, Innovative Portfolio will have direct oversight to lead the global, US, and EU regulatory strategy and delivery associated with the innovative portfolio working in partnership with the Global Program Teams, other functions in R&D, commercial, and GPS. Key focus is on new MOAs, drug delivery systems, drug-device combinations, biologics and in the rare disease space.
Responsibilities
- Provide leadership of global, US, and EU regulatory leads to create and drive the regulatory strategy for the innovative portfolio and ensure that there is a sound regulatory foundation to help drive the clinical development and LCM opportunities of the portfolio.
- The leader and their team have primary responsibility for the global regulatory strategy, regulatory interactions, and submissions, with direct accountability for US and EU centralized procedure and input with EU affiliates for national procedures (where applicable).
- Plays a leadership role providing management and guidance across the strategy function.